Liver Disease Clinical Trials in Indiana

34 recruiting studies across 1 city

Browse by City

All Trials in Indiana

Phase

Trial	Phase	Sponsor	Dist.
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis	Phase 3	Zydus Therapeutics Inc.	<1 mi
DILIN - Prospective Study	—	Duke University	<1 mi
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)	—	Target PharmaSolutions, Inc.	<1 mi
Measuring Patient Reported Needs in Outpatient Liver Disease Management	—	Indiana University	<1 mi
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema	Phase 2	Sanofi	<1 mi
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition	Phase 2	Regeneron Pharmaceuticals	<1 mi
Fibrosis Lessens After Metabolic Surgery	Phase 4	Ali Aminian	<1 mi
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease	Phase 1	Zydus Therapeutics Inc.	<1 mi
SAMe Trial for Patients With Alcoholic Cirrhosis	Phase 2	Indiana University	<1 mi
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease	N/A	Indiana University	<1 mi
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
A-LiNK: Improving Outcomes in Autoimmune Liver Disease	—	Children's Hospital Medical Center, Cincinnati	<1 mi
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease	Phase 2	GlaxoSmithKline	<1 mi
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection	Phase 2	Gilead Sciences	<1 mi
Functional Assessment in Liver Transplantation	—	University of California, San Francisco	<1 mi
Genetic Collection Protocol	—	Arbor Research Collaborative for Health	<1 mi
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome	Phase 3	Albireo, an Ipsen Company	<1 mi
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial	Phase 2	Samer Gawrieh	<1 mi
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)	Phase 2	Altimmune, Inc.	<1 mi
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease	Phase 1	Zydus Therapeutics Inc.	<1 mi
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)	Phase 3	Takeda	<1 mi
TReatment for ImmUne Mediated PathopHysiology	Phase 2	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	<1 mi
Drug-Induced Liver Injury (DILI) Network Retrospective	—	Duke University	<1 mi
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein	Phase 3	Takeda	<1 mi
A Prospective Database of Infants With Cholestasis	—	Arbor Research Collaborative for Health	<1 mi
Primary Sclerosing Cholangitis in Children	—	Arbor Research Collaborative for Health	<1 mi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH	Phase 3	Akero Therapeutics, Inc	<1 mi
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients	N/A	Indiana University	<1 mi
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)	N/A	Perspectum	<1 mi
National Liver Cancer Screening Trial	Phase 4	University of Texas Southwestern Medical Center	<1 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	Phase 3	Children's Oncology Group	<1 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors	Phase 1/2	Children's Oncology Group	<1 mi
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial	Phase 3	ECOG-ACRIN Cancer Research Group	<1 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors	Phase 1	Exelixis	<1 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.